Table 1.
Before HSCT | 6 months post HSCT | |
---|---|---|
IgG (mg/dl) | 52 | 571 |
IgA (mg/dl) | <5 | 57 |
IgM (mg/dl) | <5 | 51 |
CD4+ (c/μl) | 1,840 | 818 |
CD8+ (c/μl) | 450 | 613 |
CD4+/CD8+ | 4.1 | 1.3 |
CD20+ (c/μl) | 1,329 | 588 |
CD20+IgD+CD27− (c/μl) | 1,329 | 588 |
CD20+IgD−CD27+ (c/μl) | 0 | 7 |
CD56+ (c/μl) | 208 | 148 |
CD14+ (c/μl) | 913 | 292 |
CD66b+ CD49d− (c/μl) | 2,040 | 3,723 |
Chimerism (BM) (% autologous portion) | – | 1–5 |
Chimerism (blood) (% autologous portion) | – | 2.9 |
Immunoglobulins (Ig) G, A, A were measured in the serum by ELISA. T helper cells (CD4+), cytotoxic T cells (CD8+), B cells (CD20+), naïve B cells (CD20+IgD+CD27−), memory B cells (CD20+IgD− CD27+), NK-cells (CD56+), monocytes (CD14+), neutrophilic granulocytes (CD66b+CD49d−) were measured by flow cytometry. Chimerism analysis in bone marrow (BM) and blood was performed using molecular genetic methods or XY-Fish, respectively.